Pharmaceutical

Summary

Table of Contents

  • Publication date: December 2009
Keywords : clinical trial

Summary The author has released its latest research, “The Future of e-Clinical Trial Solutions - Market Forecasts to 2015, Competitive Benchmarking and Case Studies” which provides key data and analysis of the major factors affecting the market for e-Clinical trial solutions in the pharmaceuticals industry. The report also analyzes the strengths, weaknesses, opportunities and threats in the e-Clinical trial solutions market and ...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Robyn

(866) 682 9815

Send Your Request

Share

Global Pharmaceutical Industry : Latest Reports

Clinical Trial Management Systems (CTMS) Market: Global Trends, Opportunities, Challenge and Forecasts (2011 - 2016)

Clinical Trial Management Systems (CTMS) Market: Global Trends, Opportunities, Challenge and Forecasts (2011 - 2016)

  • $ 4 650
  • Industry report
  • January 2012
  • by MarketsandMarkets

Clinical Trial Management Systems (CTMS) Market: Global Trends, Opportunities, Challenge and Forecasts (2011 - 2016) A clinical trial deals with the application of specific clinical or scientific methods ...

Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success

Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success

  • $ 3 500
  • Industry report
  • February 2012
  • by GBI Research

Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success Summary GBI Research, the leading business intelligence provider, ...

Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases% Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation

Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases% Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation

  • $ 3 500
  • Industry report
  • April 2012
  • by GBI Research

Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation Summary GBI Research, the leading business ...


Global Pharmaceutical Industry : Latest Downloads

U.S. Pharmaceutical Industry

U.S. Pharmaceutical Industry

  • Industry report
  • May 2012
  • 49 pages

... Manufacturing processes Fda protection o orphan drug designation granted for melphalan in the treatment of ocular melanoma, cutaneous melanoma and metastatic neuroendocrine tumors, as well ...

U.S. Pharmaceutical Industry

U.S. Pharmaceutical Industry

  • Industry report
  • May 2012
  • 31 pages
  • by Corporation

... Severe uncontrolled asthma periostin level zelboraf metastatic melanoma braf v600e mutation t-dm1 metastatic breast cancer her2 expression level mericitabine and danoprevir hepatitis c hcv ...

Cancer Market in Russian Federation

Cancer Market in Russian Federation

  • Industry report
  • April 2012
  • 9 pages

... Pioneering new revolutionary technology in targeted therapy to treat cancer problem Cancer: 2nd death rate in the world colorectal cancer: 3rd most common cancer colorectal ...

Global Drug Market

3 months ago

Related Market Segments :

Clinical Trial
Clinical Research

Company Profiles

1 Companies

Bristol-Myers Squibb Co.

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.